- Company Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
-
S-3 Filing
Oxford Immunotec Global S-3Shelf registration
Filed: 25 Nov 14, 12:00am
Exhibit 12.1
Statement Regarding Computation of Ratio of Earnings to Fixed Charges
| Fiscal Year Ended December 31, | Nine Months Ended September | ||||||||||||||||||||||
($ in thousands) | 2009 | 2010 | 2011 | 2012 | 2013 | 30, 2014 | ||||||||||||||||||
Ratio of earnings to fixed charges: | ||||||||||||||||||||||||
Pre-tax loss | $ | (13,349 | ) | $ | (11,993 | ) | $ | (13,223 | ) | $ | (15,034 | ) | $ | (8,572 | ) | $ | (15,403 | ) | ||||||
Fixed charges | ||||||||||||||||||||||||
Interest expense (a) | 40 | 23 | 4 | 1,478 | 329 | 104 | ||||||||||||||||||
Interest within rental expense (b) | 146 | 194 | 196 | 227 | 236 | 223 | ||||||||||||||||||
Total fixed charges | 186 | 217 | 200 | 1,705 | 565 | 327 | ||||||||||||||||||
Total earnings (loss) | $ | (13,163 | ) | $ | (11,776 | ) | $ | (13,023 | ) | $ | (13,329 | ) | $ | (8,007 | ) | $ | (15,076 | ) | ||||||
Ratio of earnings to fixed charges | — | — | — | — | — | — | ||||||||||||||||||
Ratio of coverage deficiency | (c) | (c) | (c) | (c) | (c) | (c) |
| (a) | Interest expense includes interest on loan balances and the amortization of debt discounts and debt issuance costs. We had no debt at December 31, 2013 or at September 30, 2014. |
| (b) | Includes an estimated interest factor of the rent expense for each period presented, which management believes is a reasonable approximation of the interest component of such rentals. |
| (c) | Due to the loss from operations for the years ended December 31, 2009, 2010, 2011, 2012, and 2013, and for the nine months ended September 30, 2014, there were insufficient earnings of $13.3 million, $12.0 million, $13.2 million, $15.0 million, $8.6 million, and $15.4 million, respectively, to cover fixed charges. |